ACCREDITATION
Developments in Ureteroscopic Stone Treatment
2025 DUST Annual Meeting
August 14 – 16, 2025
Chicago
Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Developments in Ureteroscopic Stone Treatment. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco Joint Accreditation Provider Number: 4008163 Professions in scope for this activity are listed below.
Physicians
Amedco LLC designates this live activity for a maximum of 14.50 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioners
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit. Up to 14.50 hours.
Physician Assistants
The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification for PAs.
Amedco LLC designates this live activity for a maximum of 14.50 AMA PRA Category 1 CreditsTM. PAs should claim only the credit commensurate with the extent of their participation in the activity.
Objectives – After Attending This Program You Should Be Able To
- Demonstrate the indications and methodology of dusting technique during ureteroscopic laser lithotripsy when treating patients with kidney stone disease using both holmium and thulium lasers.
- Explain the effect of different laser settings and be able to select appropriate settings in different patients, to provide safe and effective stone surgery.
- Appraise the evidence on intrarenal pressure, suction for stone surgery, and ureteroscopic stone treatment quality of life, patient selection and patient outcomes.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)
All individuals in a position to control the content of CE are listed below.
| Name | Commercial Interest: Relationship |
|---|---|
| Jodi Antonelli | NA |
| William Atallah | Boston Scientific, Cook Medical, Ambu: Consultant |
| D Duane Baldwin | Prevastone, Steplite, Alaramed: Scientific/Medical Advisory Board Member Hugemed: Speakers Bureau Vathin, Lumibird: Consultant |
| Naeem Bhojani | Boston Scientific: Consultant Boston Scientific, Olympus, Laborie, AMT, Procept Biorobotics, J and J: Consultant |
| Pablo Contreras | Baltic AR: Consultant PUSEN, BSCI, Cook Medical, Promedon: Speakers Bureau |
| Sandra Defebaugh | NA |
| Esteban Emiliani Sanz | Boston Scientific, Cook Medical, Pusen, Devicare: Speakers Bureau Novo Nordisk, Storz: Consultant |
| Khurshid Ghani | Blue Cross Blue Shield of Michigan, PCORI: Research Grant Overall Principal Investigator Boston Scientific, Coloplast: Research Grant Site Principal Investigator Boston Scientific, Ambu, Karl Storz, Coloplast, Olympus, Lumibird: Consultant Urogen: Scientific/Medical Advisory Board Member |
| Mantu Gupta | Olympus Medical, Cook Medical: Speakers Bureau Boston Scientific Inc: Scientific/Medical Advisory Board Member |
| Brett Johnson | NextMed: Scientific/Medical Advisory Board Member |
| Helene Jung | Ambu: Consultant |
| Hyung Joon Kim | NA |
| Amy Krambeck | Boston Scientific, Wolf, Storz: Consultant |
| Michael Lipkin | Boston Scientific, Cook Medical, Olympus: Consultant Storz, Novo Nordisk, Ambu: Scientific/Medical Advisory Board Member |
| William Roberts | Boston Scientific: Research Grant Overall Principal Investigator Calyxo: Consultant Boston Scientific: Scientific/Medical Advisory Board Member |
| Dennis Sitek | NA |
| Sri Sivalingam | BD (Bard), Fortec Medical, Cook, Storz, Ambu: Consultant |
| Karen Stern | Boston Scientific, BD, Olympus, Dornier, Avvio, Mendaera: Consultant Calyxo: Other Sonomotion: Private Stock Shareholder |
| Wilson Sui | Karl Storz, Boston Scientific Corporation: Consultant |
| Joel Teichman | NA |
| Cortney Thibodeau | NA |
| Bristol Whiles | Boston Scientific, Karl Storz, Mokan Labs, LLC: Consultant |
| Tracy Sandstrom | NA |